New Phase III Trial Data for Caplyta Reinforces Strategic Value of $14.6 Billion Acquisition, Signaling a New...
The landscape of American pharmaceutical pricing is currently defined by a high-stakes legislative experiment. President Donald Trump’s...
For many patients, a cancer diagnosis marks the beginning of a profound, often traumatic transformation. While the...
Introduction: Answering the Call in the Shadow of an Epidemic In 1985, the city of San Francisco...
By [Your Name/Journalistic Staff] Published September 21, 2026 The headline arrived in the digital ether with a...
In the modern landscape of clinical medicine, the management of chronic and acute wounds remains a silent...
In a significant milestone for cardiac health technology, Israel-based medical device innovator CardiaCare has successfully closed an...
TORONTO, ON — In a landmark decision for oncology and supportive care, Health Canada has announced the...
New Orleans, USA – Otsuka Pharmaceutical Development & Commercialisation and Otsuka Pharmaceutical have unveiled promising expanded Phase...
In a significant milestone for thoracic oncology, long-term data from the Phase III ADAURA trial has solidified...
